Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Tony Blau is Professor in the Department of Medicine/Hematology and Adjunct Professor in the Department of Genome Sciences at the University of Washington (UW). He serves as attending physician on the leukemia service for the Seattle Cancer Care Alliance, a world-class cancer treatment center that unites doctors from the Fred Hutchinson Cancer Research Center (FHCRC), UW Medicine and Seattle Children's Hospital. Dr. Blau co-directs the Institute for Stem Cell and Regenerative Medicine at the UW and the Program for Stem and Progenitor Cell Biology at the UW/FHCRC Cancer Consortium. His research centers on exploiting the latest scientific discoveries for the benefit of patients. He pioneered a method for placing transplanted cells under the “remote control” of small molecule drugs, and has a track record of bringing together laboratories with diverse types of expertise to tackle important problems. Dr. Blau has served on numerous advisory panels for the National Institutes of Health (NIH) and currently chairs the Molecular and Cellular Hematology study section at NIH. He received his medical degree from Ohio State University and completed his residency in internal medicine at Duke University.